Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R ANDRES

Showing results (331-340 of 382) with videos related to

Pageof 39
Sort By:
Blood|May 8, 2009
Differential signal transduction, membrane trafficking, and immune effector functions mediated by FcgammaRI versus FcgammaRIIaXilei Dai, Manikandan Jayapal, Hwee Kee Tay, et al.
Journal of Medicinal Chemistry|July 9, 2019
Development of Inhibitors against <i>Mycobacterium abscessus</i> tRNA (m<sup>1</sup>G37) Methyltransferase (TrmD) Using Fragment-Based ApproachesAndrew J Whitehouse, Sherine E Thomas, Karen P Brown, et al.
Diabetes|April 1, 1997
Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studiesS L Edelstein, W C Knowler, R P Bain, et al.
Plos Biology|June 5, 2026
Disrupting phage liquid crystalline droplets restores antibiotic susceptibility in Pseudomonas aeruginosa biofilmsAbul K Tarafder, Miles Graham, Luke K Davis, et al.
Nature Communications|March 7, 2017
Regulation of phagocyte triglyceride by a STAT-ATG2 pathway controls mycobacterial infectionClaire B Péan, Mark Schiebler, Sharon W S Tan, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
A general platform for targeting MHC-II antigens via a single loopHaotian Du, Jingjia Liu, Kevin M Jude, et al.
Thorax|October 22, 2017
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)Charles S Haworth, John Banks, Toby Capstick, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2024
Lipoarabinomannan modification as a source of phenotypic heterogeneity in host-adapted <i>Mycobacterium abscessus</i> isolatesKavita De, Juan M Belardinelli, Arun Prasad Pandurangan, et al.
Journal of Medicinal Chemistry|January 26, 2022
Discovery of Novel Inhibitors of Uridine Diphosphate-<i>N</i>-Acetylenolpyruvylglucosamine Reductase (MurB) from <i>Pseudomonas aeruginosa</i>, an Opportunistic Infectious Agent Causing Death in Cystic Fibrosis PatientsMarta Acebrón-García-de-Eulate, Joan Mayol-Llinàs, Matthew T O Holland, et al.
Brain, Behavior, and Immunity|February 2, 2020
Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's diseaseRuwani S Wijeyekoon, Deborah Kronenberg-Versteeg, Kirsten M Scott, et al.
Pageof 39

Showing results (331-340 of 382) with videos related to

Sort By:
Pageof 39
Blood|May 8, 2009
Differential signal transduction, membrane trafficking, and immune effector functions mediated by FcgammaRI versus FcgammaRIIaXilei Dai, Manikandan Jayapal, Hwee Kee Tay, et al.
Journal of Medicinal Chemistry|July 9, 2019
Development of Inhibitors against <i>Mycobacterium abscessus</i> tRNA (m<sup>1</sup>G37) Methyltransferase (TrmD) Using Fragment-Based ApproachesAndrew J Whitehouse, Sherine E Thomas, Karen P Brown, et al.
Diabetes|April 1, 1997
Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studiesS L Edelstein, W C Knowler, R P Bain, et al.
Plos Biology|June 5, 2026
Disrupting phage liquid crystalline droplets restores antibiotic susceptibility in Pseudomonas aeruginosa biofilmsAbul K Tarafder, Miles Graham, Luke K Davis, et al.
Nature Communications|March 7, 2017
Regulation of phagocyte triglyceride by a STAT-ATG2 pathway controls mycobacterial infectionClaire B Péan, Mark Schiebler, Sharon W S Tan, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
A general platform for targeting MHC-II antigens via a single loopHaotian Du, Jingjia Liu, Kevin M Jude, et al.
Thorax|October 22, 2017
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)Charles S Haworth, John Banks, Toby Capstick, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2024
Lipoarabinomannan modification as a source of phenotypic heterogeneity in host-adapted <i>Mycobacterium abscessus</i> isolatesKavita De, Juan M Belardinelli, Arun Prasad Pandurangan, et al.
Journal of Medicinal Chemistry|January 26, 2022
Discovery of Novel Inhibitors of Uridine Diphosphate-<i>N</i>-Acetylenolpyruvylglucosamine Reductase (MurB) from <i>Pseudomonas aeruginosa</i>, an Opportunistic Infectious Agent Causing Death in Cystic Fibrosis PatientsMarta Acebrón-García-de-Eulate, Joan Mayol-Llinàs, Matthew T O Holland, et al.
Brain, Behavior, and Immunity|February 2, 2020
Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's diseaseRuwani S Wijeyekoon, Deborah Kronenberg-Versteeg, Kirsten M Scott, et al.
Pageof 39